Avalo Therapeutics (AVTX) EBIT Margin (QoQ) (2016 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -176,775.00 |
| Dec 31, 2023 | 24,783.00 |
| Sep 30, 2023 | -47,701.00 |
| Jun 30, 2023 | 73,897.00 |
| Mar 31, 2023 | -86,267.00 |
| Dec 31, 2022 | -101,567.00 |
| Sep 30, 2022 | 117,241.00 |
| Jun 30, 2022 | 63,273.00 |
| Mar 31, 2022 | 642,453.00 |
| Dec 31, 2021 | -698,280.00 |
| Sep 30, 2021 | -70,893.00 |
| Jun 30, 2021 | 595,456.00 |
| Mar 31, 2021 | -537,367.00 |
| Dec 31, 2020 | 10,360.00 |
| Sep 30, 2020 | -31,202.00 |
| Jun 30, 2020 | 25,760.00 |
| Mar 31, 2020 | -15,531.00 |
| Dec 31, 2019 | -85,532.00 |
| Sep 30, 2019 | 5,306.00 |
| Jun 30, 2019 | 1,120.00 |
| Mar 31, 2019 | -21,894.00 |
| Dec 31, 2018 | 62,135.00 |
| Sep 30, 2018 | -47,646.00 |
| Jun 30, 2018 | -3,647.00 |
| Mar 31, 2018 | 14,425.00 |
| Dec 31, 2017 | -31,555.00 |
| Sep 30, 2017 | 121,239.00 |
| Jun 30, 2017 | -63,054.00 |
| Mar 31, 2017 | 43,226.00 |
| Dec 31, 2016 | 92,829.00 |
| Sep 30, 2016 | -131,863.00 |